[Cable News] CSPC Pharmaceutical Group's profits more than doubled in the first three quarters. Net profit exceeded RMB 7 billion, and revenue rose by 26% to over RMB 25 billion, with revenue from Chinese patent medicines increasing by 40%.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
[Cable News] CSPC Pharmaceutical Group's profits more than doubled in the first three quarters. Net profit exceeded RMB 7 billion, and revenue rose by 26% to over RMB 25 billion, with revenue from Chinese patent medicines increasing by 40%.